68-Ga-NOTA-cyclic (NGR) peptide

N/A

Report date: 2025/01/26 16:56:15

Base Information

Drug Name68-Ga-NOTA-cyclic (NGR) peptide

Drug Alias NameN/A

ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionAminopeptidase N modulators

TargetsAminopeptidase N

Therapy Area/IndicationsReperfusion InjuryKidney NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHungary

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesScanoMed Ltd

China Registration ClassN/A

Active CompaniesScanoMed Ltd

Inactive CompaniesN/A

Active IndicationsReperfusion InjuryKidney Neoplasms

Inactive IndicationsNeoplasms

ATC CodeN/A